Tag: percent-since
-
Valeant sets earnings date, shares jump on hope for positive news
(Reuters) – Valeant Pharmaceuticals International Inc , the subject of intense scrutiny over its business practices and pricing policies, said it would release preliminary quarterly results and guidance on March 15, raising hopes the company will serve up some positive news after months of uncertainty. Valeant's stock – which had plunged 24 percent since the…
-
Sanofi pledges stable 2016 earnings
By Matthias Blamont and Noëlle Mennella PARIS (Reuters) – Sanofi said it expected stable earnings per share this year after reporting lower fourth-quarter income on Tuesday, hurt by declining sales of diabetes and cancer treatments and other prescription drugs. The French drugmaker, which is in the midst of a reorganisation to address falling sales of…
-
Valeant to appoint interim CEO as Pearson remains hospitalized: source
By Sneha Banerjee and Carl O'Donnell (Reuters) – Valeant Pharmaceuticals International Inc will appoint an interim chief executive officer to replace Michael Pearson who is hospitalized, a source familiar with the matter told Reuters, news that sent shares down 7 percent on Tuesday. The source did not clarify whether the CEO would be temporary or…
-
Valeant to appoint interim CEO as Pearson remains hospitalized: source
By Sneha Banerjee and Carl O'Donnell (Reuters) – Valeant Pharmaceuticals International Inc will appoint an interim chief executive officer to replace Michael Pearson who is hospitalized, a source familiar with the matter told Reuters, news that sent shares down 7 percent on Tuesday. The source did not clarify whether the CEO would be temporary or…